For Penn
For Industry
PCI Ventures
Innovation at Penn
Info
Available Technologies
Browse Penn-owned technologies available for licensing.
HOME
SEARCH
RSS FEED
Search Results - immunology
9
Results
Sort By:
Published Date
Title
ID
Descending
Ascending
Gum-health promoting smart dental implant system
Dental implant that inhibits plaque accumulation and gingival tissue inflammation by photobiomodulation therapy delivered by embedded light-emitting diodes (LEDs) powered by electricity generated from the patient’s own oral motion.Problem: More than half of adults will lose one or more teeth in their lifetime. When a patient loses a tooth the...
Published:
2/9/2021
Inventor(s):
Geelsu Hwang
Keywords(s):
Bioengineering
,
Cell Therapy
,
Dentistry
,
Immunology
,
Immunoncology
,
Infectious Disease
,
Inflammation
Category(s):
Medical Devices
Rapid pathogen diagnostic through amplification of red blood cell-associated DNA
Problem: Sepsis, an overwhelming and life-threatening response to infection, is the most common cause of death in US hospitals. Sepsis is associated with a mortality rate of 25–30% and mortality due to septic shock is 50–85%. Rapid diagnosis and intervention in sepsis are essential given an increased mortality rate of 8% for every hour...
Published:
11/24/2020
Inventor(s):
Nilam Mangalmurti
Keywords(s):
COVID-19
,
Immunology
,
Infectious Disease
,
Inflammation
Category(s):
Diagnostics
Rapid and ultrasensitive SARS-CoV-2 antigen detection for acute COVID-19 screening in community settings
A portable point-of-care device for rapid and sensitive detection of acute SARS-CoV-2 infections. Problem: The COVID-19 pandemic has infected over 40 million people worldwide as of mid-October 2020, causing more than 1 million deaths. Up to 50-80% of transmissions occur from asymptomatic patients. Current tests can have a turnaround time of hours...
Published:
11/11/2020
Inventor(s):
Ping Wang
Keywords(s):
COVID-19
,
Immunology
,
Infectious Disease
,
Microfluidics
,
Pulmonary
Category(s):
Diagnostics
Novel inhibitors of ferroptosis
Novel derivatives of oleic acid effectively inhibiting ferroptosis that could be used for treatment of Friedreich Ataxia, neurodegenerative diseases, and neuropsychiatric diseases. Problem: Ferroptosis is a non-apoptotic form of cell death characterized by the iron-dependent accumulation of toxic lipid-reactive oxygen species. Ferroptosis has been...
Published:
10/16/2020
Inventor(s):
Robert Wilson
,
Maria Cotticelli
,
Shujuan Xia
,
Donna Huryn
,
Amos Smith
,
Taehee Lee
,
Roberto Forestieri
Keywords(s):
Antibody
,
Cell Therapy
,
Immunology
,
Immunoncology
,
Oncology
Category(s):
Therapeutics & Vaccines
Lipid nanoparticle-based mRNA delivery for CAR T-cell engineering
A library of ionizable lipid nanoparticles (LNPs) was screened for ability to deliver mRNA to T-cells, leading to an optimized LNP formulation for delivery of mRNA to T-cells. This thereby enhances the ability to generate transient chimeric antigen receptor (CAR)-expressing T-cells for cancer immunotherapy.Problem: Chimeric antigen receptor (CAR) T-cells...
Published:
5/4/2020
Inventor(s):
Margaret Billingsley
,
Carl June
,
Nathan Singh
,
Michael Mitchell
Keywords(s):
Bioengineering
,
COVID-19
,
Drug Delivery
,
Immunology
,
Immunotherapy
Category(s):
Therapeutics & Vaccines
Therapeutic targets for T-cell lymphomas and other types of cancer
Interdependence of oncogenic and epigenetic mechanisms in T-cell lymphoma. Technology Overview: Anaplastic large cell lymphoma (ALCL) is a highly malignant type of Non-Hodgkin’s T cell lymphoma in which chromosomal translocation leads to the expression of a fusion oncoprotein Tyrosine Kinase - Nucleophosmin/Anaplastic Lymphoma Kinase or NPM/ALK. Dr....
Published:
3/20/2020
Inventor(s):
Mariusz Wasik
Keywords(s):
Immunology
,
Oncology
Category(s):
Therapeutics & Vaccines
Fully human anti-mesothelin CAR with low immunogenicity for in vivo persistence of anti-tumor engineered T cells
The fully human CAR targets mesothelin, a surface protein overexpressed in several cancer types. P4, a human antibody fragment that binds human mesothelin with high specificity, is fused to T cell signaling domains such as 28z. The T cells engineered to express this CAR are shown to shrink tumors in a mouse model bearing human ovarian tumors overexpressing...
Published:
1/29/2020
Inventor(s):
Daniel Powell
Keywords(s):
Antibody
,
Cell Therapy
,
Immunology
,
Immunoncology
,
Oncology
Category(s):
Therapeutics & Vaccines
Monoclonal antibody to CXCR6
CXCR6 is a chemokine receptor expressed by leukocytes and other cells, and is believed to play a role in cancer metastasis, gut mucosal integrity, autoimmunity, diabetes and other inflammatory disorders. It is also used by SIV as a co-receptor for target cell entry. Technology Overview: Current commercially available monoclonal antibodies that...
Published:
1/28/2020
Inventor(s):
Ronald Collman
Keywords(s):
Antibody
,
Immunology
,
Oncology
Category(s):
Research Tools & Reagents
A method to identify modulators for regulatory T cell functions
Technology Overview: Maintenance of tolerance to self-antigens is essential for the prevention of autoimmunity. This process is known to involve specific regulatory T cells (Treg) and the expression of the forkhead family transcription factor, FOXP3. FOXP3 is a “sufficient” regulator of the development and function of peripheral Treg...
Published:
8/10/2017
Inventor(s):
Mark Greene
Keywords(s):
Immunology
Category(s):
Research Tools & Reagents